These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3989917)

  • 1. Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry.
    Staiano-Coico L; Huffman J; Wolf R; Pinsky CM; Herr HW; Whitmore WF; Oettgen HF; Darzynkiewicz Z; Melamed MR
    J Urol; 1985 May; 133(5):786-8. PubMed ID: 3989917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.
    Herr HW; Pinsky CM; Whitmore WF; Sogani PC; Oettgen HF; Melamed MR
    J Urol; 1986 Feb; 135(2):265-7. PubMed ID: 3511284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
    Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ
    J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
    Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.
    Bretton PR; Herr HW; Kimmel M; Fair WR; Whitmore WF; Melamed MR
    J Urol; 1989 Jun; 141(6):1332-6. PubMed ID: 2724430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.
    Kelley DR; Ratliff TL; Catalona WJ; Shapiro A; Lage JM; Bauer WC; Haaff EO; Dresner SM
    J Urol; 1985 Jul; 134(1):48-53. PubMed ID: 3892051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors.
    Hudson MA; Yuan JJ; Catalona WJ; Ratliff TL
    J Urol; 1990 Dec; 144(6):1362-4. PubMed ID: 2231927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder.
    Vegt PD; Witjes JA; Witjes WP; Doesburg WH; Debruyne FM; van der Meijden AP
    J Urol; 1995 Mar; 153(3 Pt 2):929-33. PubMed ID: 7853577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors.
    Kavoussi LR; Torrence RJ; Gillen DP; Hudson MA; Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1988 May; 139(5):935-40. PubMed ID: 3361667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.
    Bretton PR; Herr HW; Kimmel M; Whitmore WF; Laudone V; Oettgen HF; Fair WR
    J Urol; 1990 Apr; 143(4):710-2; discussion 712-3. PubMed ID: 2313796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
    J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
    Herr HW; Badalament RA; Amato DA; Laudone VP; Fair WR; Whitmore WF
    J Urol; 1989 Jan; 141(1):22-9. PubMed ID: 2908949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
    Lamm DL; DeHaven JI; Shriver J; Sarosdy MF
    J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma of bladder after successful intravesical therapy with Bacillus Calmette-Guérin.
    Brenner DW; Yore LM; Schellhammer PF
    Urology; 1989 Aug; 34(2):93-5. PubMed ID: 2763404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical observation of 8 cases of carcinoma in situ of the urinary bladder].
    Murase T; Ito H; Ohishi M; Takashi M
    Hinyokika Kiyo; 1989 Apr; 35(4):583-5. PubMed ID: 2735263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local bacillus Calmette-Guerin therapy for superficial bladder cancer: clinical, histological and ultrastructural patterns.
    Rigatti P; Colombo R; Montorsi F; Centemero A; Guazzoni G; Di Girolamo V; Galli L; Trabucchi E
    Scand J Urol Nephrol; 1990; 24(3):191-8. PubMed ID: 2237295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin.
    deKernion JB; Huang MY; Lindner A; Smith RB; Kaufman JJ
    J Urol; 1985 Apr; 133(4):598-601. PubMed ID: 3981707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology.
    Badalament RA; Gay H; Cibas ES; Herr HW; Whitmore WF; Fair WR; Melamed MR
    J Urol; 1987 Oct; 138(4):763-5. PubMed ID: 3656528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.
    Chade DC; Shariat SF; Godoy G; Savage CJ; Cronin AM; Bochner BH; Donat SM; Herr HW; Dalbagni G
    J Urol; 2010 Jul; 184(1):74-80. PubMed ID: 20546806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.